#In Vitro Fertilization Market 2024

[janetushar1]

In Vitro Fertilization Market to Hit $1024.2 Million by 2032

The global In Vitro Fertilization Market was valued at USD 617.5 Million in 2024 and it is estimated to garner USD 1024.2 Million by 2032 with a registered CAGR of 8.8% during the forecast period 2024 to 2032.

Global In Vitro Fertilization Market Research Report 2024, Growth Rate, Market Segmentation, In Vitro Fertilization Market. It affords qualitative and quantitative insights in phrases of market size, destiny trends, and nearby outlook In Vitro Fertilization Market. Contemporary possibilities projected to influence the destiny capability of the market are analyzed in the report. Additionally, the document affords special insights into the opposition in particular industries and diverse businesses. This document in addition examines and evaluates the contemporary outlook for the ever-evolving commercial enterprise area and the prevailing and future outcomes of the market.

Get Sample Copy of Report @ https://www.vantagemarketresearch.com/in-vitro-fertilization-market-1649/request-sample

** Note: You Must Use A Corporate Email Address OR Business Details.

The Major Players Profiled in the Market Report are:-

The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific Inc. (US), Esco Micro PTE. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), Fertipro NV (Belgium), Gynotec B.V. (Netherlands) and others.

In Vitro Fertilization Market 2024 covers powerful research on global industry size, share, and growth which will allow clients to view possible requirements and forecasts. Opportunities and drivers are assembled after in-depth research by the expertise of the construction robot market. The In Vitro Fertilization Market report provides an analysis of future development strategies, key players, competitive potential, and key challenges in the industry.

Global In Vitro Fertilization Market Report 2024 reveals all critical factors related to diverse boom factors inclusive of contemporary trends and traits withinside the worldwide enterprise. It affords a complete review of the top manufacturers, present-day enterprise status, boom sectors, and commercial enterprise improvement plans for the destiny scope.

The In Vitro Fertilization Market document objectives to offer nearby improvement to the market using elements inclusive of income revenue, destiny market boom rate. It gives special observation and analysis of key aspects with quite a few studies strategies consisting of frenzy and pestle evaluation, highlighting present-day market conditions. to be. Additionally, the document affords insightful records approximately the destiny techniques and opportunities of worldwide players.

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/in-vitro-fertilization-market-1649/0

Global In Vitro Fertilization Market, By Region

1) North America- (United States, Canada, Mexico, Cuba, Guatemala, Panama, Barbados, and many others)

2) Europe- (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, and many others)

3) the Asia Pacific- (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam, and many others)

4) the Middle East & Africa- (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria, and many others)

5) Latin America- (Brazil, Argentina, Colombia, Chile, Peru, and many others)

This In Vitro Fertilization Market Research/analysis Report Contains Answers to your following Questions

What trends, challenges, and barriers will impact the development and sizing of the global market?

What is the In Vitro Fertilization Market growth accelerator during the forecast period?

SWOT Analysis of key players along with its profile and Porter’s five forces analysis to supplement the same.

How much is the In Vitro Fertilization Market industry worth in 2019? and estimated size by 2024?

How large is the In Vitro Fertilization Market? How long will it keep growing and at what rate?

Which section or location will force the market and why?

What is the important thing current tendencies witnessed in the In Vitro Fertilization Market?

Who are the top players in the market?

What and How many patents are filed by the leading players?

What is our Offering for a bright industry future?

The Research Objectives of this Report are to:-

Company, key regions/countries, merchandise and applications, historical records from 2018 to 2022, and global In Vitro Fertilization Market till 2032. Study and analyze the market length (cost and volume).

To recognize the structure of In Vitro Fertilization Market via way of means of figuring out its numerous subsegments.

In Vitro Fertilization Market on the subject of the primary regions (with every essential country). Predict the cost and length of submarkets.

To examine the In Vitro Fertilization Markets with appreciation to person boom trends, destiny prospects, and their contribution to the general market.

To examine aggressive trends consisting of expansions, contracts, new product launches, and acquisitions withinside the market.

Strategic profiling of key gamers and complete evaluation of growth strategies.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/in-vitro-fertilization-market-1649

Reasons to Buy Market Report

The market record presents a qualitative and quantitative analysis of the market based on segmentation that includes each economic and non-economic element.

In Vitro Fertilization Market through the region. The market evaluation highlights the consumption of products/services in areas and well-known shows elements influencing the market in every region.

In Vitro Fertilization Market. It consists of an in-depth analysis of the market from specific views via Market Porter's Five Forces Analysis and provides insights into the market via the Value Chain.

The In Vitro Fertilization Market file provides an outline of market fee (USD) information for every segment and sub-segment.

It consists of an in-depth analysis of the market from distinct views via a 5 forces analysis of the In Vitro Fertilization Market and offers insights into the market through the fee chain.

Check Out More Reports

Global Flow Chemistry Market:  Report Forecast by 2032

Global Pneumatic Tube System Market: Report Forecast by 2032

Global Food Authenticity Testing Market: Report Forecast by 2032

Global Lvdt Displacement Sensors Market: Report Forecast by 2032

Global Silica Analyzer Market: Report Forecast by 2032

[coochiequeens]

Since I touched on this with the articles about Jojo Siwa already planning on having 1 girl and 2 boys and the twibling article with the gay men who just happened to have had two boys through surrogacy ........

Rise in parents engaging in sex-selection during IVF has the fertility biz booming

By Cassy Fiano-Chesser | May 14, 2024 

The fertility industry has opened new doors for countless would-be parents across the globe, and it’s not just doors allowing them to have children. Thanks to in-vitro fertilization (IVF), people can create their children and then have them tested to ensure they meet all the right specifications. While this brave new world sounds like something out of a science fiction novel, it’s all too real – and using IVF to select the kind of child you want is becoming more and more common.

In 2021, socialite and reality television alum Paris Hilton announced her plans to use IVF to create her family, and choosing the sex of her babies was one of the reasons. “Well, we have been doing the IVF. So I can pick twins if I like. Kim [Kardashian] is actually the one who told me about that, I didn’t even know anything about it. And I’m happy she told me that advice, and introduced me to her doctor, so yeah. We have them all ready to go,” she said, continuing, “I think it’s just something most women should do, just to have. And then you can pick if you want boys or girls — just because I really want to have twins that are a boy and a girl. The only way to 100% get that is by making it happen that way.”

Hilton is hardly alone. The number of people foregoing sex in favor of IVF in order to have children is growing — as is sex selection. Though, according to the Daily Mail, sex selection is illegal in most of the globe, it isn’t in the United States, and it’s become trendy.

“The market is the size of the human race,” Jeffrey Steinberg, founder of the Fertility Institutes in Los Angeles, said in an interview with Slate. He claimed 85% of his clients are drawn in by the idea of choosing their baby’s sex.

Sex selection has long been practiced, albeit not using IVF; instead, parents sometimes found out the sex of their baby during an ultrasound, and if it was the “wrong” sex, they sought an abortion. Though this has typically been a way to bolster a cultural preference for boys, Slate pointed out that in the United States, it’s become the opposite: the market is skewed toward girls.

Sharon Moayeri, the founder of OC Fertility in Newport Beach, California, does not market the ability to choose the baby’s sex as aggressively as Steinberg does, and therefore, said only around 15% of her clients arrive without fertility issues. Another doctor at the medical center at the University of California San Francisco told Slate that “single mothers by choice, same-sex couples, and families with a history of autism” were typically more likely to request girls. A study also found that white parents having their first child chose female embryos 70% of the time.

"When I think about having a child that’s a boy, it’s almost a repulsion, like, Oh my God, no,” one woman said.

Another argued, “Boy children tend to be less caring towards their parents. It doesn’t really matter if it’s socialized or biological. It’s probably socialized, but I can’t change all of society.”

And because laws in other countries ban sex selection, thousands of people fly to the United States each year just to take advantage of this country’s lax fertility regulations. And it means big business for the fertility industry.

“It’s a moneymaking industry,” Laura Kerwin, a Harvard-trained psychologist, told Slate. “People need to realize that [clinics] have a fiduciary duty to their shareholders to make money. They’re trying to sell you on an option.”

There is little to no oversight within the fertility industry, meaning there is little to no information on what the current state of the industry is. “We do not even know how many frozen embryos we have in this country,” Margaret Marsh, a professor at Rutgers University, told the Atlantic, explaining that the last count — 400,000 — was 20 years ago. “[Today] we have no idea.”

The Atlantic also noted that 75% of fertility clinics advertise sex-selection as an offered service, allowing people to undergo IVF simply because they want to choose if they have a boy or a girl. Steinberg told the Atlantic this “service” makes the fertility industry approximately $90 million each year.

Steinberg also scoffed at the notion of increased regulations, saying it is “putting the handcuffs on scientists.” Then, using pro-abortion terminology, he added, “If there’s anything society should have learned, it’s ‘Keep their hands off of people’s reproductive choices’.”

IVF, though often described as a way to help heartbroken infertile couples to create families, has created a monster in which children are no longer treated as human beings, but as products to be designed, engineered, and then sold to the highest bidder upon demand. And as these embryonic children are products, they can be screened, destroyed, traded, and even turned into jewelry.

Any attempts to cut back on this commodification is swiftly attacked as cruelty towards the infertile — but what about the children being created? What will it take for the line to be drawn and a stop be placed on this reproductive free-for-all?

I checked on that statement about embryos turned into jewelry and found articles mostly dating back to 2018. But it did happen.

https://www.genethique.org/jewellery-made-from-supernumerary-embryos-obtained-after-ivf/?lang=en

"When I think about having a child that’s a boy, it’s almost a repulsion, like, Oh my God, no,” one woman said. While I get that I'm still creeped out about this being a big international business.

[aarunresearcher]

The United States in vitro fertilization market size reached USD 161 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 385.6 Million by 2033, exhibiting a growth rate (CAGR) of 9.1% during 2025-2033. The increasing rates of infertility in women, the ongoing research and development activities to improve IVF techniques, and the trend of delaying parenthood to pursue education and careers represent some of the key factors driving the market.

[marketsndata]

Global In-Vitro Fertilization Market Size, Share, Growth and Forecast 2031

Global in-vitro fertilization market is projected to witness a CAGR of 7.52% during the forecast period 2024-2031, growing from USD 29.05 billion in 2023 to USD 51.89 billion in 2031. The market demand for in-vitro fertilization is anticipated to thrive drastically in the forecast years due to rising awareness and the growing interest of investors and market players.

In-vitro fertilization is one of the types of assisted reproductive technology and is the most common approach made in the care of patients with difficulty in conceiving. This is a procedure in which eggs are removed from a woman’s ovary and then combined with sperm outside the body to form embryos. The embryos are grown in the laboratory for a few days and then either placed in a woman’s uterus or cryopreserved (frozen) for future use, which is also called in-vitro fertilization. 

Infertility could be attributable to various lifestyle factors, including smoking, heavy alcohol consumption, and obesity. Infertility is a global health issue affecting millions of people of reproductive age worldwide. For instance, according to a report published by the World Health Organization (WHO) in April 2023, around 17.5% of the adult population – roughly 1 in 6 worldwide suffer from infertility problems. The new estimates indicate that limited regional difference exists in the prevalence of infertility. The rates were quite balanced among high-, middle- and low-income countries, making it a major burden for healthcare across the globe. The report further stated that the lifetime prevalence of infertility was at 17.8% among high-income countries, and among low- and middle-income countries, was at 16.5%. For instance, in May 2023, Artificial Intelligence In-vitro Fertilization (AIVF) Ltd., a developer of AI-based solutions for in-vitro fertilization clinics, and Genea Biomedx Pty Ltd., a global provider of medical devices for IVF laboratories, announced the launch of their integrated system. The new consolidated solution is aimed at providing safe personalized, optimized IVF care to a mass population.

Increased Prevalence of Infertility Rate to Support the Growth of IVF Market

Increased prevalence of infertility is one of the major factors which led to the growth of the market for in-vitro fertilization. Various socioeconomic factors, like late marriage and childbirth, and lifestyle factors, like bad diet, obesity, and stress, have led to higher rates of infertility across the world. Moreover, certain medical conditions, like polycystic ovary syndrome, endometriosis, and male infertility, are also becoming increasingly perceived, with these factors often complicating conception. Advanced medical technology, fertility options awareness, and the changing nature of social values toward assisted reproduction will only augment these increasing demands for in-vitro fertilization services. People and couples put more emphasis on planning for family-building and finding necessary fertility solutions. Thus, to cater to the increasing demand, fertility clinics are offering a wide portfolio of services and investing in various advanced technologies to ensure higher success rates, such as genetic screening and enhanced embryo culture techniques. This increased demand fuels growth for the IVF market. For instance, in August 2024, Fresenius SE & Co. KGaA’s U.S.-based subsidiary – Fresenius Kabi USA launched U.S. Food and Drug Administration (FDA) approved Cetrorelix Acetate injection kit. Cetrorelix Acetate injection is a prescription medicine for the hormonal treatment of ovarian stimulation.

Awareness and Advancements in Technology to Drive IVF Market Growth

Awareness and technological advances are vital drivers in the IVF market. The increase in public knowledge regarding infertility and the availability of treatment options has reflected greater acceptance of assisted reproductive technologies. Advances in technology, including better techniques for embryo culture, preimplantation genetic testing, and improvements in cryopreservation, have greatly increased the success rates of IVF treatment. This also makes the procedures more effective and can increase the number of options available to a patient, including genetic screening and the possibility of freezing eggs or embryos for future use. Fertility clinics increasingly embrace high-tech facilities to attract and retain patients and further foster market growth. With continued spreading awareness and technological advancements, the IVF market will expand steadily in the future. For instance, in December 2023, the U.S. FDA cleared the first over-the-counter artificial insemination kit manufactured by Mosie Inc. The approval of the artificial insemination kit is expected to drive the market by making fertility treatments more accessible, affordable, and inclusive.  

Culture Media Segment to Dominate the In-Vitro Fertilization Market

The culture media segment is forecast to dominate the market for in-vitro fertilization as it represents a crucial component in support of embryonic development and significant improvement of success rates. The culture media provides the minimum amount of nutrients and optimal conditions for embryos to be cultured outside the human body, making it an indispensable part of the IVF process. Advanced formulation techniques have ensured that these media work well and are tailored to different embryo development stages. However, the increasing impetus around personalized medicine and precision reproductive care requires demand for well-designed culture media for each patient that will ensure superior results. Accordingly, with increasing fertility treatments around the world and increasing cycles of IVF, the demand for high-quality culture media grows further.

Consequently, with unrelenting research and development, the growth in the culture media market is foreseen to be sturdy, which places it in a great position to fuel general growth in the IVF market. For instance, in July 2022, FUJIFILM Irvine Scientific, which develops and manufactures cell culture media and assisted reproductive technologies, announced the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil that comes with optimal weight viscosity for the perfect balance of ease of use and protection.                                                                    

North America Dominates In-Vitro Fertilization Market

North America is leading the IVF market because of advanced medical technology, higher fertility treatment awareness, and strong healthcare infrastructure. It has a huge number of fertility clinics with specialized staff and well-equipped professionals. According to clinic-specific assisted reproductive technologies (ART) data released by the Society for Assisted Reproductive Technology (SART). In 2022, IVF babies increased by 2.5%, from 89,208 in 2021 to 91,771 in 2022. That represents 2.5% of all births in the U.S. and translates to successful ART cycles. Increased reports of cycle numbers point to the continued steady growth in demand for fertility services, even hostile legislation and threats of political interference. The total number of IVF cycles performed at the 368-member clinics of the Society for Assisted Reproductive Technology (SART) has grown by over 6% from 2021, from 368,502 in 2021 to 389,993 in 2022.

For instance, in February 2024, Femasys Inc., a biomedical company, received approval from the FDA for FemaSeed, a First-Line Infertility Treatment Option. Femasys is preparing for the commercial launch of FemaSeed in the U.S. There is a rise in the incidence of infertility due to late pregnancies and lifestyle factors and increased demand for assisted reproductive technology. Available treatment options, favorable policies, and certain insurance coverage contribute to more promising prospects for the growth of this market. Moreover, further research and development in applied reproductive technologies, including embryo culture techniques and genetic screening, keeps North America on top of the IVF industry. As societal attitudes toward fertility treatment increasingly change, such factors as the growing acceptance of fertility treatments show that North America will continue to dominate the market for IVF for the foreseeable future.

Download Free Sample Report

Future Market Scenario (2024-2031F)

The future market scenario of the in-vitro fertilization (IVF) market is poised for significant growth, driven by increased awareness of reproductive health, technological advancement, greater communication around reproductive health issues, and better social attitudes. With rising acceptance and a growing ability to access fertility treatments, many couples are looking toward IVF as a viable option for building families. The others include the improved success rate through technological advancement in embryo selection, advanced genetic screening, and even better culture media, therefore leading to tailoring treatment plans to improve further patient experiences, where focus is increasingly placed on personalized medicine. Another area that continues to expand is fertility preservation services, specifically egg and sperm freezing, which are adopted by younger demographics. For instance, in April 2023, Cryoport, Inc. signed a 3-year agreement with Boston IVF, LLC, a pioneer in reproductive healthcare and innovative research and one of the world’s most experienced fertility treatment providers.

Report Scope

“In-Vitro Fertilization Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global in vitro fertilization market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/in-vitro-fertilization-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[industrynewsupdates]

Key Trends Driving the Preimplantation Genetic Testing Market

The global preimplantation genetic testing (PGT) market was valued at approximately USD 802.2 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. Several factors are contributing to this growth, notably the rising prevalence of genetic disorders such as single gene, mitochondrial, and other hereditary conditions. As awareness of genetic risks increases, there is a growing demand for preimplantation diagnosis and screening processes to ensure healthier pregnancies and reduce the risk of passing on genetic diseases.

For example, the Florida Department of Health reports that one in every 33 babies in the U.S. is born with a congenital disability, which affects approximately 120,000 babies each year. These statistics highlight the importance of genetic testing, as more families seek options to prevent the transmission of such disorders. As advancements in genetic testing continue, the demand for preimplantation genetic testing is expected to increase. For instance, in July 2023, Thermo Fisher Scientific Inc. launched two new Next-Generation Sequencing (NGS)-based tests specifically designed for preimplantation genetic testing for aneuploidy (PGT-A). This addition reflects the continued innovation in the field and its potential to drive market growth in the coming years.

Preimplantation genetic diagnosis (PGD) plays a critical role in the in vitro fertilization (IVF) process, particularly for individuals or couples with a history of miscarriages or those who have experienced pregnancies involving chromosomal abnormalities. PGD is typically used in IVF cycles to help ensure a successful pregnancy by identifying embryos that do not carry genetic disorders or chromosomal abnormalities. This testing is especially beneficial for couples who are at risk for hereditary genetic disorders, offering them a chance to have a healthy child and preventing the transmission of genetic diseases.

Gather more insights about the market drivers, restrains and growth of the Preimplantation Genetic Testing Market

Regional Insights

North America accounted for a significant share of the global preimplantation genetic testing (PGT) market, driven by a combination of factors such as the rising prevalence of various genetic disorders, increasing number of laboratories offering PGT services, and heightened awareness of genetic screening. The market is also buoyed by a high incidence of hereditary disorders and other common diseases, such as Polycystic Ovary Syndrome (PCOS) and chlamydia, which further increase the demand for genetic testing. The adoption of advanced reproductive technologies, such as in-vitro fertilization (IVF) with PGT to prevent genetic disorders, has significantly contributed to the growth in this region.

U.S. 

In the United States, the PGT market is witnessing steady growth, fueled by increasing awareness about hereditary disorders, advancements in reproductive technologies, rising infertility rates, and a growing preference for personalized medicine. Moreover, supportive government regulations and a high demand for IVF procedures have further driven market expansion. As more individuals seek fertility solutions that enable them to have healthy offspring, the demand for PGT services is expected to increase, contributing to the overall growth of the market in the U.S.

Europe 

Europe dominated the global PGT market in 2023, accounting for 40.74% of the total revenue share. This leadership is primarily driven by a high volume of IVF procedures, which have been increasingly adopted due to the trend of late pregnancies among women in Europe. Additionally, the liberal regulations surrounding aneuploidy screening in many European countries, coupled with the presence of established market players and healthcare providers, are helping to propel the growth of the PGT market in the region.

The UK market for preimplantation genetic testing is also expected to see significant growth due to government policies that support IVF, along with funding initiatives and a rising demand for personalized medicine. These factors, combined with better IVF success rates, will drive the adoption of PGT solutions across the country.

In Germany, the PGT market is set for growth as increasing public awareness about genetic disorders and the benefits of PGT is prompting more couples to opt for genetic testing before pregnancy. As these trends continue, Germany will see continued market expansion.

Asia Pacific 

The Asia Pacific region is poised to register the highest CAGR of 11.3% during the forecast period. This growth is fueled by advancements in reproductive technology, expanding healthcare accessibility, and a greater awareness of PGT across the region. Countries like China and Japan are leading the way in the integration of advanced genetic testing technologies within reproductive health practices, helping to boost the demand for PGT services.

In China, the growing burden of genetic diseases and a large population with significant hereditary disorders are driving the demand for preimplantation genetic testing. With a high adoption rate of IVF procedures, the need for PGT to ensure healthy births by selecting embryos free of genetic mutations is expected to fuel market growth.

Similarly, Japan is seeing increasing demand for PGT due to technological innovations in genetic testing and heightened awareness of the benefits of genetic screening. These factors, combined with an increasing number of couples opting for assisted reproductive technologies, will contribute to the growth of the PGT market in Japan.

Latin America 

The Latin American market for preimplantation genetic testing is expected to experience substantial growth, primarily driven by increasing awareness of genetic disorders. As people become more educated about the risks of hereditary diseases, the demand for proactive genetic testing during family planning is expected to rise.

In Brazil, the market is poised for significant growth due to the entry of new providers and the introduction of advanced genomic technologies. These innovations are enhancing the accuracy and range of conditions that can be screened through PGT, expanding the market's potential in the country.

Middle East and Africa (MEA) 

In the MEA region, the preimplantation genetic testing market is also expected to grow significantly, driven by increasing awareness of the importance of genetic screening and diagnosis. The region has seen a positive shift in attitudes toward hereditary diseases, with more people recognizing the benefits of PGT.

The UAE is experiencing growth in the PGT market, supported by a cultural shift toward acceptance of advanced medical technologies. As social attitudes evolve positively toward genetic testing, Emiratis and expatriates alike are more likely to consider PGT for family planning. This change is further supported by an increasingly progressive healthcare infrastructure that facilitates the adoption of innovative medical technologies.

In Kuwait, technological advancements in hereditary testing technologies are driving the growth of the PGT market. Enhanced accuracy and reliability in genetic testing are contributing to better outcomes for couples undergoing assisted reproductive treatments, thereby boosting demand for PGT services.

Browse through Grand View Research's  Clinical Diagnostics Industry Research Reports.

• The tissue diagnostics market size was estimated at USD 8.72 billion in 2024 and is projected to grow at a CAGR of 8.41% from 2025 to 2030.

• The global ovarian cancer diagnostics market was valued at USD 4.60 billion in 2023 and is expected to grow at a CAGR of 5.0% during the forecast period.

Key Preimplantation Genetic Testing Company Insights

Several key players dominate the global preimplantation genetic testing (PGT) market, including Quest Diagnostics Incorporated, Natera, Inc., and Illumina, Inc. These companies are driving innovation and expanding their reach through a variety of strategies, such as new product launches, strategic acquisitions, and partnerships with healthcare providers.

• Illumina, Inc. is a leading player in the genomics and sequencing industry, providing advanced tools and technologies that enable the accurate analysis of DNA. Their solutions are widely used across healthcare, agriculture, and scientific research, helping to drive advancements in personalized medicine and genetic testing.

• Quest Diagnostics Incorporated is a major medical diagnostics company that offers clinical testing services, including gene-based testing, routine testing, and drugs-of-abuse testing. Their services are critical for healthcare providers, and their global presence, including in Mexico, India, Ireland, and the UK, enhances their capacity to serve diverse markets. Their diagnostic laboratories are key partners in expanding access to PGT and other advanced testing technologies.

Key Preimplantation Genetic Testing Companies:

The following are the leading companies in the preimplantation genetic testing market. These companies collectively hold the largest market share and dictate industry trends.

• Quest Diagnostics Incorporated

• Natera, Inc.

• COOPER SURGICAL, INC.

• Genea Pty Limited.

• Invitae Corporation

• Laboratory Corporation of America Holdings

• Thermo Fisher Scientific Inc.

• Bioarray S.L.

• Illumina, Inc.

• Igenomix

• RGI

• F. Hoffmann-La Roche Ltd

Order a free sample PDF of the Preimplantation Genetic Testing Market Intelligence Study, published by Grand View Research.

[insightfulblogz]

Assisted Reproductive Technology Market: In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2032

Assisted Reproductive Technology (ART) refers to a range of medical procedures used to treat infertility, with the most common being in vitro fertilization (IVF). ART has revolutionized the way individuals and couples experiencing fertility challenges can achieve pregnancy. It involves the manipulation of eggs, sperm, or embryos to increase the likelihood of conception. ART is widely used for women with blocked fallopian tubes, male infertility issues, or unexplained infertility. With advancements in technology and medical expertise, ART success rates have improved, offering hope to millions of people worldwide who face infertility challenges.

The Assisted Reproductive Technology (ART) Market is expected to reach USD 45.75 Bn by 2032 and was valued at USD 27.13 Bn in 2023 the CAGR growth rate will be 5.98% over the forecast period of 2024-2032.

Future Scope

The future of ART looks promising with the advent of new technologies and medical research focused on increasing pregnancy success rates while reducing health risks. Innovations such as improved egg and sperm freezing techniques, genetic screening of embryos, and the development of artificial wombs are at the forefront of ART advancements. Research into gene editing for correcting genetic abnormalities in embryos is also gaining traction, potentially reducing the risk of inherited diseases. Moreover, the use of artificial intelligence (AI) is expected to optimize embryo selection processes, further improving the success rates of ART procedures.

Trends

A major trend in ART is the increasing use of preimplantation genetic testing (PGT), which screens embryos for genetic abnormalities before implantation, thus improving the chances of a healthy pregnancy. Additionally, egg freezing (oocyte cryopreservation) is becoming more popular among women who wish to delay childbirth for personal or medical reasons. The rise of donor eggs and sperm banks is also making ART more accessible to a wider demographic. Another key trend is the growing use of minimally invasive procedures to improve patient comfort and reduce recovery times. Telemedicine is also playing a role in ART consultations, providing patients with easier access to fertility specialists.

Applications

Assisted Reproductive Technology has a wide range of applications. IVF, the most well-known form, involves fertilizing an egg outside the body and transferring the resulting embryo into the uterus. Intracytoplasmic sperm injection (ICSI) is used for male infertility, where a single sperm is injected directly into an egg. Egg and sperm donation programs allow individuals with fertility issues to use donor genetic material. Gestational surrogacy is another application where a woman carries and delivers a child for someone else. Additionally, fertility preservation techniques like egg or embryo freezing provide options for individuals facing medical treatments, such as chemotherapy, that could impact fertility.

Key Points

Assisted Reproductive Technology (ART) offers various solutions for individuals and couples facing infertility.

Advancements in genetic screening and AI are improving success rates for ART procedures.

Egg freezing and embryo cryopreservation are becoming more common for fertility preservation.

ART applications include IVF, ICSI, egg and sperm donation, and surrogacy.

Telemedicine is increasing access to fertility care and consultation.

Conclusion

The field of Assisted Reproductive Technology has made significant strides in addressing infertility, offering individuals and couples a variety of options to achieve pregnancy. As technology continues to advance, ART success rates are expected to improve further, while innovations such as AI-driven embryo selection and gene-editing techniques are on the horizon. The future of ART is bright, with an increasing focus on making treatments more accessible, personalized, and successful. With continued research and development, ART is set to play an even greater role in helping people overcome infertility challenges.

Read More Details: https://www.snsinsider.com/reports/assisted-reproductive-technology-market-3447 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND) 

[health-views-updates]

In Vitro Fertilization Market Analysis and Industry Research Report to 2032

The global In Vitro Fertilization market revenue is set for significant growth, with market value rising from USD 18.82 billion in 2023 to an anticipated USD 35.83 billion by 2032. This expansion represents a compound annual growth rate (CAGR) of 7.47% over the forecast period from 2024 to 2032, driven by advancements in reproductive technologies, increasing infertility rates, and rising awareness and acceptance of IVF treatments globally.

In Vitro Fertilization (IVF) is a widely used assisted reproductive technology (ART) that helps couples conceive by fertilizing an egg outside the body, followed by implantation into the uterus. The growing demand for fertility treatments, supported by technological advancements and favorable government initiatives, continues to boost the IVF market worldwide.

Key Market Drivers

Increasing Infertility Rates: Rising infertility rates, influenced by lifestyle changes, delayed childbearing, stress, and various health issues, are one of the primary drivers of the IVF market. According to the World Health Organization (WHO), infertility affects around 15% of reproductive-aged couples globally. As more individuals face challenges in natural conception, the demand for IVF treatments is expected to surge, driving market growth.

Technological Advancements in Assisted Reproductive Technologies (ART): Continuous advancements in ART, including improvements in embryo selection, genetic testing, cryopreservation, and minimally invasive procedures, are contributing to the expansion of the IVF market. New technologies like time-lapse imaging and artificial intelligence (AI)-driven embryo analysis are enhancing success rates and making IVF more effective, leading to greater adoption among patients.

Rising Awareness and Acceptance of IVF: Social acceptance of IVF and other fertility treatments has significantly increased in recent years, thanks to growing awareness and advocacy efforts. Public campaigns, celebrity endorsements, and educational initiatives have helped reduce the stigma around infertility and IVF treatments, encouraging more couples to seek medical intervention. Additionally, the availability of fertility financing options and insurance coverage in some regions has made IVF more accessible.

Delayed Parenthood Trends: The trend of delayed parenthood, especially among working professionals, is driving the demand for fertility treatments like IVF. As individuals and couples prioritize careers and financial stability, the average age for first-time pregnancies is increasing, leading to a greater likelihood of fertility challenges. This has resulted in a growing market for assisted reproductive technologies to help individuals conceive later in life.

Favorable Government Initiatives: Several governments around the world are introducing policies to support fertility treatments, providing funding or offering subsidies for IVF procedures. Countries such as Australia, Denmark, and Israel have implemented programs that make fertility treatments more affordable and accessible. This support is expected to positively impact the growth of the IVF market.

Get a Sample Report@ https://www.snsinsider.com/sample-request/1053 

Challenges and Opportunities

While the IVF market is growing rapidly, it faces challenges, including the high cost of treatment, limited access in certain regions, and emotional and physical demands on patients. IVF procedures can be expensive, and affordability remains a key barrier, particularly in lower-income countries. However, advancements in treatment methods and increasing financial support from both governments and private entities are expected to reduce costs over time.

Opportunities in the IVF market lie in expanding access to treatments, especially in developing regions where fertility services are still limited. Companies are investing in opening new fertility clinics and offering telemedicine consultations to reach a broader patient base. Moreover, innovations such as genetic screening and AI-driven embryo selection can further improve success rates and patient outcomes, creating opportunities for further market growth.

Regional Insights

North America currently holds the largest share of the IVF market, driven by well-established healthcare infrastructure, advanced fertility clinics, and the high prevalence of infertility. Europe is also a major market, with countries like the UK, France, and Germany offering strong support for IVF services through public and private healthcare systems.

The Asia-Pacific region is expected to witness the highest growth during the forecast period, fueled by a growing population, rising awareness about fertility treatments, and improving healthcare infrastructure. Countries such as India, China, and Japan are becoming prominent markets for IVF due to increasing infertility rates and the rising availability of affordable fertility services.

Future Outlook

As IVF technologies continue to advance and societal acceptance grows, the market is poised for robust expansion over the next decade. The increasing prevalence of infertility, combined with greater access to treatment options and supportive government initiatives, will drive market demand globally. With a projected CAGR of 7.47% from 2024 to 2032, the global IVF market is expected to more than double in value, reaching USD 35.83 billion by 2032.

In conclusion, the IVF market is entering a period of sustained growth, driven by rising infertility rates, technological innovation, and greater awareness and accessibility of fertility treatments. The industry's future holds significant opportunities for improving treatment success rates and expanding access to IVF services, ensuring that more individuals can fulfill their dreams of parenthood.

Other Trending Reports

Immunology Market Trends

Medical Imaging Devices Market Trends

Healthcare Mobility Solutions Market Trends

Diabetes Devices Market Trends

[heathcareforallworld]

The Future of Oocyte Retrieval Products: Market Trends and Innovations for 2032

The oocyte retrieval product market, essential in the assisted reproductive technology (ART) sector, is poised for substantial growth and transformation as we approach 2032. This market encompasses various tools and technologies designed for the collection of oocytes, or eggs, from the ovaries, a crucial step in in vitro fertilization (IVF) and other fertility treatments. As advancements in reproductive medicine continue to evolve, several key trends and factors are expected to shape the future of this market.

Oocyte Retrieval Product Market Size was estimated at 16.41 (USD Billion) in 2023. The Oocyte Retrieval Product Market Industry is expected to grow from 18.57 (USD Billion) in 2024 to 50.0 (USD Billion) by 2032. The Oocyte Retrieval Product Market CAGR (growth rate) is expected to be around 13.18% during the forecast period (2025 - 2032).

Technological Advancements

One of the primary drivers of growth in the oocyte retrieval product market is the rapid advancement in technology. Innovations in retrieval techniques and tools have significantly improved the efficiency and safety of the oocyte collection process. Modern systems now incorporate enhanced imaging technologies, such as ultrasound-guided retrieval and advanced laparoscopic techniques, which increase precision and reduce the risk of complications. Additionally, automated retrieval systems are becoming more prevalent, offering greater consistency and reducing the manual effort required from medical professionals.

Market Expansion

The oocyte retrieval product market is expected to expand as ART procedures become more accessible globally. Increasing awareness about fertility issues and the rising acceptance of ART are contributing to a higher demand for oocyte retrieval products. Emerging markets in Asia-Pacific, Latin America, and the Middle East are showing significant potential due to growing healthcare infrastructure and rising disposable incomes. As more individuals and couples seek fertility treatments, the demand for advanced oocyte retrieval technologies is likely to increase.

Regulatory and Quality Standards

Regulatory frameworks and quality standards are crucial in ensuring the safety and efficacy of oocyte retrieval products. As the market evolves, regulatory bodies are expected to impose stricter guidelines to address concerns related to product safety and effectiveness. Compliance with international standards will be essential for manufacturers aiming to gain a competitive edge. Companies that invest in research and development to meet these standards and improve product quality will be better positioned to succeed in the market.

Customization and Patient-Centric Approaches

Personalized medicine is becoming a significant trend in the healthcare industry, and the oocyte retrieval product market is no exception. Customization of retrieval tools to suit individual patient needs and preferences is gaining traction. Advances in genomics and patient-specific data analysis are enabling the development of tailored solutions that enhance the success rates of ART procedures. This patient-centric approach not only improves outcomes but also boosts patient satisfaction, driving further demand for specialized oocyte retrieval products.

Challenges and Opportunities

Despite the positive outlook, the oocyte retrieval product market faces several challenges. High costs associated with advanced retrieval technologies can limit accessibility for some patients, particularly in developing regions. Additionally, there is a need for ongoing research to address issues related to the long-term safety and effectiveness of retrieval techniques. However, these challenges also present opportunities for innovation. Companies that focus on developing cost-effective solutions and addressing safety concerns will likely capture a significant share of the market.

Future Outlook

Looking ahead to 2032, the oocyte retrieval product market is expected to experience robust growth driven by technological advancements, expanding global demand, and increasing focus on personalized medicine. The integration of artificial intelligence (AI) and machine learning in retrieval systems is likely to further enhance the precision and efficiency of the process. As the field of reproductive medicine continues to advance, the oocyte retrieval product market will play a crucial role in supporting successful ART outcomes and improving fertility treatments worldwide.

[naveendsw]

In Vitro Fertilization Market Size, Share & Industry Report

[credenceresearchdotblog]

The Donor Egg IVF Market is projected to grow significantly from USD 3,326.8 million in 2024 to USD 5,889.26 million by 2032, reflecting a robust CAGR of 7.4%.The Donor Egg In Vitro Fertilization (IVF) market is experiencing significant growth worldwide, driven by various factors such as increasing infertility rates, advancements in reproductive technologies, changing societal norms, and a rising number of same-sex couples and single parents seeking reproductive assistance. This market has expanded to meet the needs of individuals and couples who face challenges in conceiving naturally, and it continues to evolve as new technologies and treatments emerge.

Browse the full report at https://www.credenceresearch.com/report/donor-egg-ivf-market

Market Overview

Donor Egg IVF is a procedure where eggs from a donor are fertilized with sperm in a laboratory setting, and the resulting embryos are transferred to the recipient's uterus. This process is particularly beneficial for women with diminished ovarian reserve, advanced maternal age, genetic disorders, or those who have undergone cancer treatments that affect fertility. It also serves as an option for same-sex male couples or single men wishing to have biological children.

As of 2024, the global Donor Egg IVF market is valued at billions of dollars, with steady growth projected over the next decade. North America and Europe dominate the market, largely due to the presence of advanced healthcare infrastructure, high awareness levels, and supportive legal frameworks. However, the Asia-Pacific region is expected to witness the fastest growth, driven by increasing awareness, rising infertility rates, and the growing acceptance of assisted reproductive technologies (ART).

Key Market Drivers

1. Rising Infertility Rates: Infertility is a growing concern worldwide, affecting millions of couples. Factors such as delayed childbearing, lifestyle changes, and environmental factors contribute to this trend. Donor Egg IVF offers a viable solution for those unable to conceive naturally, making it an increasingly popular option.

2. Advancements in Reproductive Technology: Technological advancements in IVF and related procedures have significantly improved success rates, making Donor Egg IVF a more reliable and attractive option. Innovations such as preimplantation genetic testing (PGT) and cryopreservation of eggs and embryos have further enhanced the success and accessibility of these procedures.

3. Changing Societal Norms: There is a growing acceptance of diverse family structures, including single-parent families and same-sex couples. This shift in societal norms has led to an increase in the number of individuals and couples seeking fertility treatments like Donor Egg IVF to build their families.

4. Supportive Legal and Ethical Frameworks: In many countries, the legal and ethical frameworks surrounding egg donation and IVF procedures have become more supportive, enabling more individuals to access these services. This has encouraged the growth of the Donor Egg IVF market, particularly in regions where such procedures were previously restricted.

Market Challenges

Despite its growth, the Donor Egg IVF market faces several challenges. The high cost of procedures, ethical concerns related to egg donation, and varying legal regulations across different regions can act as barriers to market expansion. Additionally, the emotional and psychological aspects of using donor eggs can be significant for recipients, requiring comprehensive counseling and support services.

Another challenge is the limited availability of egg donors, which can be a significant hurdle in certain regions. This scarcity can lead to longer waiting times and higher costs for prospective parents, potentially limiting access to these treatments.

Future Prospects

The future of the Donor Egg IVF market looks promising, with several trends likely to shape its development. The increasing use of artificial intelligence (AI) and machine learning in fertility treatments could improve success rates and make the process more efficient. Additionally, the growing popularity of cross-border reproductive care, where individuals travel to other countries for fertility treatments, is expected to further drive market growth.

Moreover, as societal attitudes continue to evolve, the demand for Donor Egg IVF is likely to increase, particularly among non-traditional families. This will likely lead to further innovations in reproductive technology and more personalized fertility treatments tailored to individual needs.

Key Player Analysis:

The Cape Fertility Clinic

Medfem Fertility Clinic

Beacon CARE Fertility

Merrion Fertility Clinic

The Montreal Fertility Center

Shanghai United Family Hospital

Morpheus Life Sciences Pvt. Ltd.

KL Fertility & Gynecology Centre

Bourn Hall Fertility Center

TMC Fertility Centre

Segmentations:

By Cycle Type

Fresh Donor Egg IVF Cycle

Frozen Donor Egg IVF Cycle

By End User

Fertility Clinics

Hospital

Surgical Centres

Clinical Research Institutes

Browse the full report at https://www.credenceresearch.com/report/donor-egg-ivf-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[coochiequeens]

Surrogacy exploits women and turns babies into commodities. This financial article "Here's how to make money off of exploited women and babies treating babies like a commissioned art piece."

By Tom van den Bosch Oct 5, 2024

Press Release, Orbis Research – Sections of the Worldwide Surrogacy Industry Report

The study on the worldwide Surrogacy market is an extensive work that addresses many different market-related topics. It contains a thorough examination of the market’s size, growth rate, and important factors throughout the duration of the forecast. In-depth market segmentation based on product categories, applications, and geographic areas is included in the study, along with performance data for each section. A comprehensive analysis of the competition landscape, including a profile of the main competitors, their market strategies, and recent developments, is also included in the research.

Request a sample report @ https://www.orbisresearch.com/contacts/request-sample/7303432

To determine the macroeconomic and geopolitical aspects impacting the market, it also includes a thorough PESTL analysis. The report delves deeper into the COVID-19 pandemic’s effects on the industry and offers insights into how companies have adjusted to the changing landscape. Furthermore, market projections from 2024 to 2034 are provided in the research, providing organizations with important information for strategic planning.

Gains for Purchasers

Purchasers can make substantial profits from the Surrogacy market, particularly in industries where implementing Surrogacy-related technology can boost productivity and cut expenses. In-depth case studies and illustrations of how major industry participants have profited from implementing Surrogacy solutions are provided in the research.

Surrogacy market Segmentation by Type:

Intrauterine insemination (IUI) In-vitro fertilization (IVF) Others

Surrogacy market Segmentation by Application:

Hospitals Fertility clinics Others

Direct Purchase the report @ https://www.orbisresearch.com/contact/purchase-single-user/7303432

Value at Market and Compound Annual Growth Rate for 2024–2034

The global Surrogacy market’s market value and compound annual growth rate (CAGR) are estimated in this study for the 2024–2034 forecast period. Based on a careful examination of past data, industry trends, and professional judgment, this estimate was made. The market is anticipated to expand at a strong rate during the course of the forecast period, with a CAGR of roughly X%. The rising need for Surrogacy-related technology in sectors including manufacturing, retail, and healthcare is the main driver of this rise. It is anticipated that the worldwide Surrogacy market will be worth roughly $X billion by 2034, offering businesses and investors substantial potential.

Key Players in the Surrogacy market:

New Hope Fertility Center IVI-RMA Global Scanfert AVA Clinic Bourn Hall Fertility Clinic Nova IVI Fertility Ovation Fertility Bangkok IVF Center Extraordinary Conceptions Cardone & Associates Reproductive Medicine & Infertility Max Healthcare Growing Generations

Circle Surrogacy Morpheus Life Sciences

Environment of Competition

The competition landscape, including major companies, their market shares, and their growth plans, is thoroughly analyzed in the report. It includes important acquisitions and mergers, collaborations, and launches of goods that have influenced the market in recent years. Businesses trying to comprehend the dynamics of competition and find possible locations for joint ventures or acquisitions may find this section especially helpful.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.orbisresearch.com/contacts/enquiry-before-buying/7303432

Advantages of the Study for Major Players

For important participants in the sector, this report on the worldwide Surrogacy market offers several significant advantages. First, it provides comprehensive market information, covering obstacles, growth drivers, and trends, enabling businesses to make wise choices. Businesses can measure their performance against competitors and find possible areas for cooperation or expansion by using the report’s thorough competitive analysis. The market prediction in the research also offers helpful advice for strategic planning, assisting important companies in foreseeing changes in the industry and maintaining an advantage over rivals. This report is an essential resource for businesses seeking to grow into new areas or increase their market share since it helps them identify opportunities and reduce risk factors.

About Us

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Phone: +1 (972)-591-8191, Email: sales@orbisresearch.com

[market-insider]

Preimplantation Genetic Testing Market Future Outlook: Analyzing Size, Share, and Growth Patterns

The global preimplantation genetic testing market size is expected to reach USD 1.54 billion by 2030, growing at 10.3% CAGR from 2024 to 2030, as per the new report by Grand View Research, Inc. Recent technological advancements in testing have changed the current practice of prenatal screening and early detection of chromosomal abnormalities in an embryo. Moreover, the introduction of novel technologies such as NGS, PCR, and FISH is expected to drive market growth over the forecast period.

Growing awareness about genetic diseases and novel techniques for the detection of chromosomal abnormalities and embryo screening for successful IVF holds growth prospects for this vertical over the forecast period. Key market players and service providers such as COOPER SURGICAL, INC. are running awareness campaigns to promote an increased understanding of the diseases and screening of these diseases at the early stages. Such favorable initiatives are expected to increase the demand for PDT in IVF procedures globally.

The increasing adoption of in vitro fertilization (IVF) technique consequently upsurges the utilization of preimplantation genetic testing (PGT). These techniques are advantageous in allowing the development of a healthy fetus and preventing the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.

Moreover, the increased risk of genetic disease in newborns and complications associated with IVF procedures push healthcare providers to recommend PGT. For instance, according to the CDC, in the U.S., about 6,000 babies are born with Down syndrome each year. It is the most common chromosomal condition diagnosed in newborns in the country. Moreover, the high risk associated with aged pregnancy further increases the adoption of PGT worldwide.

Key companies are involved in developing novel methods and solutions to carry out preimplantation genetic diagnosis and screening. To maintain their significant share in the revenue in the coming years, these participants are undertaking strategic initiatives. The strategic undertakings include regional expansion, collaborative development, and new product developments.

For instance, in October 2022, Ovation Fertility and Genomic Prediction partnered to expand genetic testing services by using the LifeView PGT platform for PFT. Moreover, in April 2022, Clevergene received PCPNDT for prenatal genetic testing. The company aimed to expand its services in preimplantation genetic screening and non-invasive prenatal testing.

For More Details or Sample Copy please visit link @: Preimplantation Genetic Testing Market Report

Preimplantation Genetic Testing Market Report Highlights

The rising incidence of genetic diseases has fueled the demand for preimplantation genetic testing (PGT). With increasing prevalence of genetic disorders, PGT has become crucial in IVF procedures.

The Polymerase Chain Reaction (PCR) segment dominated the preimplantation genetic testing market and contributed 39.8% to the market share in 2023. 

The preimplantation genetic diagnosis segment dominated the preimplantation genetic testing market and contributed 77.0% of the market share in 2023.

Europe preimplantation genetic testing market dominated the global market in 2023, capturing the largest revenue share at 40.74%.

Gain deeper insights on the market and receive your free copy with TOC now @: Preimplantation Genetic Testing Market Report

Grand View Research has segmented the global Preimplantation Genetic Testing market on the basis of procedure, product, technology, application, end use, and region.

[industrynewsupdates]

Understanding Preimplantation Genetic Testing Market: Trends and Insights

The global preimplantation genetic testing (PGT) market was estimated to be valued at USD 802.2 million in 2023, with projections indicating a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. This growth is largely driven by the increasing prevalence of single-gene, mitochondrial, and other genetic disorders, which is anticipated to elevate the demand for preimplantation diagnostic and screening processes in the upcoming years. According to the Florida Department of Health, around one in every 33 babies born in the U.S. is affected by a congenital disability, resulting in nearly 120,000 affected infants annually. As new testing options are introduced, demand for these services is expected to rise. For instance, in July 2023, Thermo Fisher Scientific Inc. launched two next-generation sequencing (NGS)-based tests specifically designed for preimplantation genetic testing for aneuploidy (PGT-A).

The integration of aneuploidy screening in preimplantation genetic diagnosis (PGD) has significantly enhanced in vitro fertilization (IVF) procedures. By utilizing aneuploidy testing in IVF centers, healthcare providers can identify embryos with chromosomal abnormalities, which leads to improved pregnancy success rates. Preimplantation genetic testing for aneuploidy (PGT-A) assesses embryos for chromosomal integrity, ensuring they possess the correct number of chromosomes. The benefits of PGT-A—such as higher chances of pregnancy, lower miscarriage rates, and fewer IVF cycles required to achieve a successful pregnancy—are expected to further stimulate the adoption of these tests in the forecast period.

Gather more insights about the market drivers, restrains and growth of the Preimplantation Genetic Testing Market

Industry Dynamics

The preimplantation genetic testing market has experienced considerable innovation, marked by advancements like PGT-A and PGT-M. These developments enhance diagnostic accuracy, mitigate risks, and improve pregnancy success rates, which collectively drive market expansion and deliver better outcomes for individuals dealing with genetic and fertility challenges.

The market landscape is characterized by key players who engage in moderate levels of product launches and merger and acquisition (M&A) activities. Companies are increasingly consolidating their resources to harness advanced technologies, broaden their market presence, and enhance their service offerings. This trend is instrumental in fostering growth and innovation within the sector, ultimately improving outcomes for patients seeking genetic and fertility solutions.

Regulatory frameworks play a significant role in shaping the preimplantation genetic testing market, ensuring that safety, efficacy, and ethical standards are maintained. Stringent regulations govern the development and implementation of testing procedures, thereby building trust among patients and healthcare practitioners. However, the complexity of these regulations can also present challenges for market entry and innovation, potentially affecting the speed of technological advancements.

In terms of alternatives, the preimplantation genetic testing market faces competition from traditional prenatal diagnostic methods, such as amniocentesis and chorionic villus sampling (CVS). Unlike PGT, these conventional methods assess genetic disorders only after pregnancy has been established, which can lead to difficult choices if abnormalities are detected. While these alternatives provide diagnostic options, they do not offer the early intervention advantages that PGT presents.

Order a free sample PDF of the Preimplantation Genetic Testing Market Intelligence Study, published by Grand View Research.